SS K12 has demonstrated potential effects in the realm of pharyngotonsillitis (21, 22) and it has also proven effective in reducing the levels of certain cytokines, such as IL-8, which play a role in the development of the inflammatory response and potentially in the pathogenesis of PFAPA (23). Here, CXCL8 is linked to PFAPA syndrome.